DNA-Templated Strontium-Doped Calcium Phosphate Nanoparticles for Gene Delivery in Bone Cells
Source abstract
Abstract
Calcium phosphates (CaPs), constituents of the inorganic phase of natural bone, are highly biocompatible and biodegradable. Strontium (Sr) regulates the formation and resorption of bone. Incorporation of Sr into CaPs may target genes of interest to bone cells while regulating their function. In this work, we developed a single-step synthesis method to prepare Sr-doped CaP nanoparticles (SrCaP-DNA NPs) by using DNA as a template for controlling the mineralization and the stability of the colloidal solution. The resulting nanoparticles were monodispersed with well-controlled size, morphology, and composition. By using this method, we were able to fabricate CaP NPs with varying contents of Sr2+. We demonstrated that the stability of CaP NPs in extracellular environments increased when Sr2+ partially replaced Ca2+ in CaP NPs. We showed that the cellular uptake of SrCaP-DNA NPs and the efficiency of gene transfer and alkaline phosphatase activity in human fetal osteoblastic cell line (hFOB1.19) were dependent on the content of Sr2+ in NPs. Together with other studies, our results suggest SrCaP-DNA NPs can be optimized for targeted gene transfer to regulate function of bone cells, enabling applications such as bone tissue engineering and treating bone diseases.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Bone Metabolism and Diseases · Orthopedic Infections and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemical Engineering, Stanford University, Shriram Center, 443 Via Ortega, Stanford, California 94305, United States
Funding
National Institute of Allergy and Infectious Diseases
References (66)
Show source-provided references
1. 10.2174/187421060181201040610.2174/1874210601812010406 ↗
2. 10.3390/ma1004033410.3390/ma10040334 ↗
3. Bienek D. R. · Biointerface Research in Applied Chemistry · 2017 · 7 · 1989
4. 10.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-110.1002/1521-3773(20020902)41:17<3130::AID-ANIE3130>3.0.CO;2-1 ↗
5. 10.1016/j.actbio.2011.11.01710.1016/j.actbio.2011.11.017 ↗
6. 10.1016/j.actbio.2010.06.03110.1016/j.actbio.2010.06.031 ↗
7. 10.1080/03639045.2018.145187910.1080/03639045.2018.1451879 ↗
8. 10.1016/j.mattod.2015.10.00810.1016/j.mattod.2015.10.008 ↗
9. 10.1007/978-981-10-5975-9_510.1007/978-981-10-5975-9_5 ↗
10. 10.1016/j.cis.2017.04.00710.1016/j.cis.2017.04.007 ↗
11. 10.1002/wnan.16310.1002/wnan.163 ↗
12. 10.2174/138161282266615121012385910.2174/1381612822666151210123859 ↗
13. 10.1007/978-1-4615-5517-9_110.1007/978-1-4615-5517-9_1 ↗
14. 10.1016/j.colsurfb.2017.06.02810.1016/j.colsurfb.2017.06.028 ↗
15. 10.1021/acsami.6b1592510.1021/acsami.6b15925 ↗
16. 10.1039/C1JM13502C10.1039/C1JM13502C ↗
17. 10.1093/nar/24.4.59610.1093/nar/24.4.596 ↗
18. 10.1039/c0jm01130d10.1039/c0jm01130d ↗
19. 10.1016/j.ymeth.2003.11.01110.1016/j.ymeth.2003.11.011 ↗
20. 10.2147/IJN.S1709610.2147/IJN.S17096 ↗
21. 10.1586/14737159.5.6.89310.1586/14737159.5.6.893 ↗
22. 10.1021/acsbiomaterials.7b0081310.1021/acsbiomaterials.7b00813 ↗
23. 10.1007/s00223001005510.1007/s002230010055 ↗
24. 10.1016/j.bone.2007.02.00310.1016/j.bone.2007.02.003 ↗
25. 10.1016/j.micron.2015.10.00610.1016/j.micron.2015.10.006 ↗
26. 10.1016/j.actbio.2017.10.03610.1016/j.actbio.2017.10.036 ↗
27. 10.1007/s11914-010-0042-z10.1007/s11914-010-0042-z ↗
28. 10.1016/j.actbio.2007.05.00610.1016/j.actbio.2007.05.006 ↗
29. 10.1007/s10856-011-4379-310.1007/s10856-011-4379-3 ↗
30. 10.1007/s10856-010-4123-410.1007/s10856-010-4123-4 ↗
31. 10.1039/C6RA21708G10.1039/C6RA21708G ↗
32. 10.1016/j.biomaterials.2010.01.04410.1016/j.biomaterials.2010.01.044 ↗
33. 10.1016/j.msec.2016.10.04710.1016/j.msec.2016.10.047 ↗
34. 10.1016/j.biomaterials.2009.08.00610.1016/j.biomaterials.2009.08.006 ↗
35. Shen Z. · J. Immunol · 1997 · 158 · 272310.4049/jimmunol.158.6.2723 ↗
36. 10.1021/nl071542i10.1021/nl071542i ↗
37. 10.1385/MB:13:1:2910.1385/MB:13:1:29 ↗
38. 10.1142/757910.1142/7579 ↗
39. 10.1021/ar200113c10.1021/ar200113c ↗
40. 10.1016/j.biomaterials.2005.12.03010.1016/j.biomaterials.2005.12.030 ↗
41. 10.1016/S0142-9612(00)00433-610.1016/S0142-9612(00)00433-6 ↗
42. 10.1038/nmat290010.1038/nmat2900 ↗
43. 10.1039/b708258d10.1039/b708258d ↗
44. 10.1002/mawe.20060001710.1002/mawe.200600017 ↗
45. 10.1126/science.155.3768.140910.1126/science.155.3768.1409 ↗
46. 10.1016/j.biomaterials.2006.11.00110.1016/j.biomaterials.2006.11.001 ↗
47. 10.1016/j.cell.2010.01.04010.1016/j.cell.2010.01.040 ↗
48. 10.1155/2010/54616310.1155/2010/546163 ↗
49. 10.1016/j.biomaterials.2009.08.04310.1016/j.biomaterials.2009.08.043 ↗
50. 10.1016/j.biomaterials.2009.02.04410.1016/j.biomaterials.2009.02.044 ↗
51. 10.1208/s12248-010-9210-410.1208/s12248-010-9210-4 ↗
52. 10.1016/S0169-409X(02)00228-410.1016/S0169-409X(02)00228-4 ↗
53. 10.1186/1477-3155-10-710.1186/1477-3155-10-7 ↗
54. 10.1016/S0005-2736(97)00194-610.1016/S0005-2736(97)00194-6 ↗
55. 10.1002/jbm.a.3197510.1002/jbm.a.31975 ↗
56. 10.1016/j.actbio.2011.07.00410.1016/j.actbio.2011.07.004 ↗
57. 10.1016/j.biomaterials.2010.05.03610.1016/j.biomaterials.2010.05.036 ↗
58. 10.1083/jcb.129.4.98910.1083/jcb.129.4.989 ↗
59. Dunn W. A. · J. Biol. Chem. · 1980 · 255 · 597110.1016/S0021-9258(19)70726-1 ↗
60. 10.1016/j.ijpharm.2004.07.03510.1016/j.ijpharm.2004.07.035 ↗
61. 10.1021/nl801988810.1021/nl8019888 ↗
62. 10.1016/B978-0-12-381978-9.10023-X10.1016/B978-0-12-381978-9.10023-X ↗
63. 10.1016/j.actbio.2008.05.00510.1016/j.actbio.2008.05.005 ↗
64. 10.1007/978-3-642-03307-0_1010.1007/978-3-642-03307-0_10 ↗
65. 10.1039/C6TB01282E10.1039/C6TB01282E ↗
66. 10.1016/j.msec.2012.12.00510.1016/j.msec.2012.12.005 ↗